COMPASS THERAPEUTICS, INC. Income Tax Expense
COMPASS THERAPEUTICS, INC. (CMPX) reported Income Tax Expense of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-03-05
- COMPASS THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2025-03-31 was $0.00.
- COMPASS THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2024-06-30 was $0.00.
- COMPASS THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2024-03-31 was $0.00.
- COMPASS THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2023-12-31 was $0.00.
- COMPASS THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2025 was $0.00.
- COMPASS THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2024 was $0.00.
- COMPASS THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2023 was $0.00.
- COMPASS THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2022 was $0.00.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-05 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-03-05 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-12 | $0.00 10-Q · filed 2024-08-12 | $0.00 derived: sum of 3 quarters · filed 2025-05-08 | $0.00 derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-05-08 | $0.00 derived: sum of 3 quarters · filed 2025-05-08 | $0.00 derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2024-08-12 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-12 | $0.00 10-Q · filed 2024-08-12 | $0.00 derived: sum of 3 quarters · filed 2024-08-12 | $0.00 derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-13 | $0.00 derived: sum of 2 quarters · filed 2024-05-13 | $0.00 derived: sum of 3 quarters · filed 2024-05-13 | $0.00 derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $0.00 derived: sum of 2 quarters · filed 2024-03-21 | $0.00 derived: sum of 3 quarters · filed 2024-03-21 | $0.00 10-K · filed 2024-03-21 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | -$13.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | -$13.00K derived: sum of 3 quarters · filed 2023-08-03 | -$13.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | -$13.00K derived: sum of 2 quarters · filed 2023-05-04 | -$13.00K derived: sum of 3 quarters · filed 2023-05-04 | $0.00 derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$13.00K derived: sum of 2 quarters · filed 2023-03-15 | $0.00 derived: sum of 3 quarters · filed 2023-03-15 | $0.00 10-K · filed 2023-03-15 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $13.00K derived: sum of 2 quarters · filed 2022-11-09 | $13.00K 10-Q · filed 2022-11-09 | $13.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $13.00K 10-Q · filed 2022-08-01 | $13.00K 10-Q · filed 2022-08-01 | $13.00K derived: sum of 3 quarters · filed 2022-08-01 | $13.00K derived: sum of 4 quarters · filed 2022-08-01 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | $0.00 derived: sum of 2 quarters · filed 2022-05-09 | $0.00 derived: sum of 3 quarters · filed 2022-05-09 | $16.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $0.00 derived: sum of 2 quarters · filed 2022-03-18 | $16.00K derived: sum of 3 quarters · filed 2022-03-18 | $32.00K 10-K · filed 2022-03-18 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-12 | $16.00K derived: sum of 2 quarters · filed 2021-11-12 | $32.00K 10-Q · filed 2021-11-12 | $42.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $16.00K 10-Q · filed 2021-08-16 | $32.00K 10-Q · filed 2021-08-16 | $42.00K derived: sum of 3 quarters · filed 2021-08-16 | $68.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $16.00K 10-Q · filed 2021-04-30 | $26.00K derived: sum of 2 quarters · filed 2021-04-30 | $52.00K derived: sum of 3 quarters · filed 2021-04-30 | $78.00K derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $36.00K derived: sum of 2 quarters · filed 2021-03-05 | $62.00K derived: sum of 3 quarters · filed 2021-03-05 | $91.00K 10-K · filed 2021-03-05 |
| 2019-09-30 | $26.00K 10-Q · filed 2020-11-09 | $52.00K derived: sum of 2 quarters · filed 2020-11-09 | $81.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $26.00K 10-Q · filed 2020-08-13 | $55.00K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |